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57%), and/or surgical procedure(s) for treatment (n= 258, 63%). Among SSIs included 
in the validation, temporally-associated antibiotics, surgical treatment procedures, 
and cultures were present for 84% (338/401), 61% (246/401), and 59% (238/401) respec-
tively. Only 5.7% (23/401) of procedures coded for SSI post-procedure had no antibiot-
ics, surgical treatment, or culture within 14 days of the SSI claim. ConClusions: 
Over 94% percent of patients identified by our claims algorithm as having an SSI 
received clinically expected treatment for infection, including surgery, cultures, and 
antibiotics, suggesting this algorithm has very good positive predictive value. This 
method may facilitate retrospective SSI surveillance and comparison of SSI rates 
across facilities and providers.
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objeCtives: Integrated delivery networks (IDNs) capture patient data across the 
continuum of care and are valuable tools for real-world research, with potential to 
study large, diverse cohorts with rich information on patient characteristics, treat-
ments, physician decisions and outcomes. However, using multiple IDNs requires 
combination of dissimilar data to create a uniform post hoc analysis dataset. We 
used this approach to create a novel cohort to examine maternal and neonatal 
characteristics with the goal of better understanding preterm labor, a critical step 
in developing effective tocolytic treatments. Methods: Retrospective data on 
births from 2001-2012 were collected from 4 U.S. IDNs (from Illinois, Ohio, New 
Mexico and central states [Missouri/Arkansas/Kansas/Oklahoma] participating in 
Quintiles’ COMparative effectiveness PAtient Safety and Surveillance (COMPASS) 
Research Network. The IDNs were geographically/racially distinct with varying types 
of electronic medical records, catchment areas and institution types. Detailed data 
specifications were defined, mothers and babies were linked using medical record 
numbers and files were pooled to produce an overall cohort. Results: A cohort of 
109,583 mother-baby pairs among women with uncomplicated, singleton pregnan-
cies was built each associated with their clinical records. Data were collected on 
maternal medication use and specific pregnancy complications (e.g., eclampsia/
HELLP, placental conditions and infections) and neonatal characteristics including 
demographics, weekly gestational age, procedures, treatments and hospital-based 
clinical outcomes. ConClusions: IDNs offer an in-depth source of real-world data 
to evaluate characteristics of otherwise difficult-to-study populations. However, 
employing routine care information from diverse settings for research presents chal-
lenges and varying definitions, coding processes and facility characteristics should 
be considered before analyses. Processes must be developed to translate clinical 
records into standardized analytic research datasets. Development of detailed speci-
fication and harmonization processes allowed creation of a cohesive and unique 
mother-baby linked data resource that could be extended to a broad range of peri-
natal epidemiology and health outcomes research questions.
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objeCtives: To estimate associations between attributes of COPD and to develop 
a model that predicts economic and health outcomes associated with COPD pro-
gression. Methods: We utilized data from ECLIPSE (clinicaltrials.gov identifier: 
NCT00292552), a three year cohort study of COPD patients to estimate the asso-
ciations between central COPD attributes (exacerbations, lung function, exercise 
capacity, and signs/symptoms) while adjusting for co-morbidities, body composition 
(BMI), biomarkers, smoking history, age, and gender. As disease progression end-
points we used the total score of the St. George’s Respiratory Questionnaire (SGRQ) 
and mortality. We applied random coefficient models to assess the relationships 
between the central COPD attributes longitudinally and thereby describe patient 
trajectories over time. As appropriate, non-linear functional forms were explored 
to characterize the nature of the data. Endogeneity among the central attributes of 
COPD was addressed by time-lagging in the regression models. Results: Severe 
exacerbations in the preceding 12-months were associated with an average decline 
in lung function (FEV1) of up to 10 ml (P< 0.05) and with a reduced exercise capacity 
(6 minute walk test) of 13 meters (P< 0.0001). A 1% increase in FEV1 % predicted was 
also associated with a 5% reduction in the probability of experiencing dyspnoea on 
most days/week (P< 0.0001). All central attributes were found to significantly impact 
disease progression, measured by the SGRQ, with the largest estimated effect for 
dyspnoea on most days/week (18 point increase in the SGRQ score; P< 0.0001). Lung 
function and exercise capacity, however, were the only central attributes that were 
significant predictors of mortality (P< 0.05). ConClusions: The use of appropriate 
analytical techniques to account for the longitudinal nature and endogeneity of 
COPD attributes enables the estimation of their impact on important health out-
comes. Our results confirm the expected associations between the central attributes 
of COPD and their effect on patient health status (SGRQ) and mortality.
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objeCtives: the association between depressive symptoms (Center for 
Epidemiologic Studies Depression Scale [CES-D]) and subsequent cognitive function 
PRM90
coMPaRison of the 4-iteM anD 8-iteM MoRisky MeDication aDheRence 
scale in Patients with tyPe 2 Diabetes
Pedersini R.1, Vietri J.2
1Kantar Health, Epsom, UK, 2Kantar Health, Milan, Italy
objeCtives: The 4-item Morisky Medication Adherence Scale (MMAS-4) and more 
recent 8-item version (MMAS-8) have both been validated and demonstrate concur-
rent validity among patients with hypertension, but the extent to which the scales 
can be compared has received little attention. This study assessed the comparabil-
ity of adherence scores obtained with these scales in patients with type 2 diabetes 
(T2D) as well as the feasibility of integrating results across the scales using 4 items 
of the MMAS-8. Methods: Data were taken from the 2011 and 2012 US National 
Health and Wellness Survey (NHWS). The NHWS is a large cross-sectional survey 
representative of the total adult population in several major markets; N~75,000/year 
in the US. A total of 13,007 respondents self-reported physician diagnosis of T2D and 
were administered MMAS-4 in 2011 or MMAS-8 in 2012. The two adherence scales 
were evaluated by comparing the frequency distributions of the MMAS scores for the 
two scales, Cronbach’s alpha and inter-item correlations, and the creation of a new 
4-item scale including the questions in MMAS-8 that best matched the questions 
in MMAS-4. Results: In T2D patients, both MMAS-4 and -8 scores are Poisson-like 
distributed, with median at zero (high adherence) for MMAS-4 and at 1 (medium 
adherence) for MMAS-8. Chronbach’s alpha was 0.55 for MMAS-4 and 0.71 for MMAS-
8, while average item-test correlations were 0.65 and 0.57, respectively. The reduced 
4-item scale created out of MMAS-8 is also Poisson-like distributed, Cronbach’s 
alpha was 0.62 and the average item-test correlation was 0.68. ConClusions: 
Scores of the two MMAS show similar qualitative and quantitative characteristics, 
suggesting that it may be appropriate to integrate data sources using the two dif-
ferent versions, particularly when the responses to the subset of 4 MMAS-8 items 
are available. Future research should confirm that the scales can be integrated in 
different therapeutic areas.
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objeCtives: We aimed to validate the telephone administration of the Revised Pre-
screening Denver Questionnaire (R-PDQ) and the Ages and Stages Questionnaire 
(ASQ), 2 tools used to pre-screen and screen children development, respec-
tively. Methods: The OTIS Antidepressants in Pregnancy Study cohort was used. 
Women were recruited through nine North American Teratogen Information 
Services and at the CHU Ste-Justine outpatient obstetrical clinic (Montreal). To be 
included, women had to be > 18 years old, < 15 weeks pregnant, and not using known 
teratogens. Both questionnaires were self and telephone- administered to mothers 
at 12-months postpartum. The ASQ includes five domains (communication, gross 
motor, fine motor, problem-solving and personal-social). The R-PDQ tests gross 
and fine motor, personal-social and language skills. Socio-demographic variables 
were collected through telephone interviews. Concordance between the telephone 
and self-administration of both questionnaires were assessed with Intraclass 
Correlation Coefficients (ICC) with 95% Confidence Intervals (CI). Results: Overall, 
61 and 56 women filled the ASQ and R-PDQ, respectively. Concordance between the 
self and telephone-administered ASQ was substantial for the communication scale 
(ICC= 0.76;95% CI (0.63;0.84)), almost perfect for the gross motor scale (ICC = 0.83; 95% 
CI (0.73; 0.90), and moderate for the fine motor, problem-solving and personal-social 
scales (ICC = 0.44; 95% CI (0.21; 0.62); ICC = 0.43; 95% CI (0.19; 0.61); ICC = 0.52; 95% CI 
(0.31; 0.68); respectively). Regarding the R-PDQ, the following concordance estimates 
were found: gross motor scale (ICC = 0.90; 95% CI (0.83; 0.94)), language (ICC = 0.58; 
95% CI (0.38; 0.72), personal-social scales (ICC = 0.27; 95% CI (0.07; 0.49). The agree-
ment was perfect for the fine motor scale. ConClusions: The telephone admin-
istration of the ASQ is a valid method of child development screening. However, 
only the R-PDQ gross and fine motor and language scales should be administered 
through telephone when pre-screening infant development.
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objeCtives: International Classification of Diseases (ICD-9-CM) diagnosis codes are 
increasingly being used to identify hospital-acquired infections, often with insuffi-
cient evidence demonstrating validity of the codes used. Absent medical record veri-
fication, we sought to confirm a claims algorithm to identify surgical site infections 
(SSI) by determining the presence of clinically expected SSI treatment. Methods: 
We performed a retrospective cohort study using private insurer claims data from 
persons < 65 years with ICD-9-CM procedure or CPT-4 codes for anterior cruciate 
ligament (ACL) reconstruction from 1/2004–12/2010. SSIs occurring within 90 days 
after ACL reconstruction were identified by ICD-9-CM diagnosis codes. Antibiotic 
utilization, surgical treatment, and microbiology culture claims within 14 days of SSI 
codes were used for validation. Results: Of 40,702 ACL reconstruction procedures, 
409 (1.0%) were complicated by SSIs, 172 (0.4%) of which were specifically identified 
as septic arthritis. Most SSIs were associated with an inpatient admission (n= 232, 
